Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten-H Ohlmann

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Expert Review of Anticancer Therapy|December 21, 2004
Ibandronate: its pharmacology and clinical efficacy in the management of tumor-induced hypercalcemia and metastatic bone diseaseAxel Heidenreich, Carsten H Ohlmann
Urologie (Heidelberg, Germany)|March 6, 2024
[Role of local treatments in prostate cancer]Carsten-H Ohlmann, Marc-Oliver Grimm
European Urology|April 24, 2007
Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomyAxel Heidenreich, Carsten H Ohlmann, Sergej Polyakov
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 15, 2019
Guideline adherence in bone-targeted treatment of cancer patients with bone metastases in GermanyHartmut Link, Ingo Diel, Carsten-H Ohlmann, et al.
BJU International|May 18, 2018
Radical prostatectomy in T4 prostate cancer after inductive androgen deprivation: results of a single-institution series with long-term follow-upTurkan Hajili, Carsten H Ohlmann, Johannes Linxweiler, et al.
Cancer|August 27, 2004
Prospective randomized Phase II trial of pegylated doxorubicin in the management of symptomatic hormone-refractory prostate carcinomaAxel Heidenreich, Frank Sommer, Carsten H Ohlmann, et al.
Anti-Cancer Drugs|April 23, 2005
Application of thalidomide/interleukin-2 in immunochemotherapy-refractory metastatic renal cell carcinomaAndres J Schrader, Axel Heidenreich, Axel Hegele, et al.
Urologia Internationalis|February 11, 2016
Organ-Preserving Surgical Treatment of a Horseshoe Kidney Occupied by a Large Renal Cell Carcinoma with Extensive Venous Invasion: A Case ReportJohannes Linxweiler, Roushanak Shayesteh-Kheslat, Peter Fries, et al.
Der Urologe. Ausg. A|February 25, 2016
[PREFERE - Study on the rise]Carsten-H Ohlmann, Michael Stöckle, Peter Albers, et al.
World Journal of Urology|November 22, 2011
Novel options for the treatment of castration-resistant prostate cancerCarsten-H Ohlmann, Axel S Merseburger, Henrik Suttmann, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Expert Review of Anticancer Therapy|December 21, 2004
Ibandronate: its pharmacology and clinical efficacy in the management of tumor-induced hypercalcemia and metastatic bone diseaseAxel Heidenreich, Carsten H Ohlmann
Urologie (Heidelberg, Germany)|March 6, 2024
[Role of local treatments in prostate cancer]Carsten-H Ohlmann, Marc-Oliver Grimm
European Urology|April 24, 2007
Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomyAxel Heidenreich, Carsten H Ohlmann, Sergej Polyakov
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 15, 2019
Guideline adherence in bone-targeted treatment of cancer patients with bone metastases in GermanyHartmut Link, Ingo Diel, Carsten-H Ohlmann, et al.
BJU International|May 18, 2018
Radical prostatectomy in T4 prostate cancer after inductive androgen deprivation: results of a single-institution series with long-term follow-upTurkan Hajili, Carsten H Ohlmann, Johannes Linxweiler, et al.
Cancer|August 27, 2004
Prospective randomized Phase II trial of pegylated doxorubicin in the management of symptomatic hormone-refractory prostate carcinomaAxel Heidenreich, Frank Sommer, Carsten H Ohlmann, et al.
Anti-Cancer Drugs|April 23, 2005
Application of thalidomide/interleukin-2 in immunochemotherapy-refractory metastatic renal cell carcinomaAndres J Schrader, Axel Heidenreich, Axel Hegele, et al.
Urologia Internationalis|February 11, 2016
Organ-Preserving Surgical Treatment of a Horseshoe Kidney Occupied by a Large Renal Cell Carcinoma with Extensive Venous Invasion: A Case ReportJohannes Linxweiler, Roushanak Shayesteh-Kheslat, Peter Fries, et al.
Der Urologe. Ausg. A|February 25, 2016
[PREFERE - Study on the rise]Carsten-H Ohlmann, Michael Stöckle, Peter Albers, et al.
World Journal of Urology|November 22, 2011
Novel options for the treatment of castration-resistant prostate cancerCarsten-H Ohlmann, Axel S Merseburger, Henrik Suttmann, et al.
Pageof 2